Unknown

Dataset Information

0

Acquisition of mitochondrial dysregulation and resistance to mitochondrial-mediated apoptosis after genotoxic insult in normal human fibroblasts: a possible model for early stage carcinogenesis.


ABSTRACT: Acquisition of death-resistance is critical in the evolution of neoplasia. Our aim was to model the early stages of carcinogenesis by examining intracellular alterations in cells that have acquired apoptosis-resistance after exposure to a complex genotoxin. We previously generated sub-populations of BJ-hTERT human diploid fibroblasts, which have acquired death-resistance following exposure to hexavalent chromium [Cr(VI)], a broad-spectrum genotoxicant. Long-term exposure to certain forms of Cr(VI) is associated with respiratory carcinogenesis. Here, we report on the death-sensitivity of subclonal populations derived from clonogenic survivors of BJ-hTERT cells treated with 5 ?M Cr(VI) (DR1, DR2), or selected by dilution-based cloning without treatment (CC1). Following Cr(VI) treatment, CC1 cells downregulated expression of the anti-apoptotic protein Bcl-2 and exhibited extensive expression of cleaved caspase 3. In contrast, the DR cells exhibited no cleaved caspase 3 expression and maintained expression of Bcl-2 following recovery from 24 h Cr(VI) exposure. The DR cells also exhibited attenuated mitochondrial-membrane depolarization and mitochondrial retention of cytochrome c and SMAC/DIABLO following Cr(VI) exposure. The DR cells exhibited less basal mtDNA damage, as compared to CC1 cells, which correlates with intrinsic (non-induced) death-resistance. Notably, there was no difference in p53 protein expression before or after treatment among all cell lines. Taken together, our data suggest the presence of more resilient mitochondria in death-resistant cells, and that death-resistance can be acquired in normal human cells early after genotoxin exposure. We postulate that resistance to mitochondrial-mediated cell death and mitochondrial dysregulation may be an initial phenotypic alteration observed in early stage carcinogenesis.

SUBMITTER: Nickens KP 

PROVIDER: S-EPMC3273576 | BioStudies | 2012-01-01

REPOSITORIES: biostudies

Similar Datasets

2009-01-01 | S-EPMC2728454 | BioStudies
| GSE12205 | GEO
2009-01-13 | E-GEOD-12205 | ArrayExpress
2012-01-01 | S-EPMC3259276 | BioStudies
2020-01-01 | S-EPMC7665134 | BioStudies
2018-01-01 | S-EPMC5825290 | BioStudies
2012-01-01 | S-EPMC3298598 | BioStudies
2013-01-01 | S-EPMC3664092 | BioStudies
2011-01-01 | S-EPMC3179675 | BioStudies
2010-01-01 | S-EPMC3005768 | BioStudies